Personensuche
X
?
1
Time to tuberculosis development and its predictors among H..:
Ajema, Abraham Teka ; Simachew, Yilkal ; Meshesha, Meiraf Daniel..
PLOS ONE. 19 (2024) 2 - p. e0298021 , 2024
PLOS ONE. 19 (2024) 2 - p. e0298021 , 2024
?
2
Treatment Outcome of MDR/RR TB in a Resource-Constrained Se..:
Omer, Abdurahman Abibeker ; Meshesha, Meiraf Daniel ; Ajema, Abraham Teka.
Infection and Drug Resistance. 15 (2022) - p. 4707-4719 , 2022
Infection and Drug Resistance. 15 (2022) - p. 4707-4719 , 2022
?
3
Treatment Outcome of MDR/RR TB in a Resource-Constrained Se..:
Omer, Abdurahman Abibeker ; Meshesha, Meiraf Daniel ; Ajema, Abraham Teka.
info:eu-repo/semantics/altIdentifier/doi/10.2147/IDR.S377238. , 2022
info:eu-repo/semantics/altIdentifier/doi/10.2147/IDR.S377238. , 2022
?
4
Kaplan—Meier survival estimate of study participants, by AR..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.g002. , 2024
doi:10.1371/journal.pone.0298021.g002. , 2024
?
5
Baseline clinical characteristics of study participants, Ha..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t002. , 2024
doi:10.1371/journal.pone.0298021.t002. , 2024
?
6
Kaplan—Meier survival estimate of study participants, Hawas..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.g001. , 2024
doi:10.1371/journal.pone.0298021.g001. , 2024
?
7
Care, treatment intervention and follow-up characteristics ..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t003. , 2024
doi:10.1371/journal.pone.0298021.t003. , 2024
?
8
Sociodemographic characteristics of study participants, Haw..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t001. , 2024
doi:10.1371/journal.pone.0298021.t001. , 2024
?
9
Bivariable and multivariable Cox proportional hazard analys..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t005. , 2024
doi:10.1371/journal.pone.0298021.t005. , 2024
?
10
S1 Dataset -:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.s001. , 2024
doi:10.1371/journal.pone.0298021.s001. , 2024
?
11
Incidence of TB among participants by study variables, Hawa..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t004. , 2024
doi:10.1371/journal.pone.0298021.t004. , 2024
?
12
Kaplan—Meier survival estimate of study participants, by TP..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.g003. , 2024
doi:10.1371/journal.pone.0298021.g003. , 2024
?
13
S1 Dataset -:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.s001. , 2024
doi:10.1371/journal.pone.0298021.s001. , 2024
?
14
Kaplan—Meier survival estimate of study participants, by AR..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.g002. , 2024
doi:10.1371/journal.pone.0298021.g002. , 2024
?
15
Care, treatment intervention and follow-up characteristics ..:
Abraham Teka Ajema ; Yilkal Simachew ; Meiraf Daniel Meshesha.
doi:10.1371/journal.pone.0298021.t003. , 2024
doi:10.1371/journal.pone.0298021.t003. , 2024